AEON BIOPHARMA INC

Historical 13F Holders

Symbol
AEON
CUSIP
00791X209
All holders as of
Q2 2026
Type
Equity
Class
CL A NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00791X209 since 12/18/2024, newest first.

Filer % of Class Filed
Timothy P. Lynch 13G 13.0% 8/21/2026
Event 8/19/2026
Stonepine Capital Management, LLC 13G
9.9% 7/21/2026
Event 7/15/2026
Alta Partners LLC 13G/A Amendment 2 2.1% 10/14/2025
Event 9/30/2025
Alta Partners LLC 13G/A Amendment 1 5.1% 7/9/2025
Event 6/30/2025
Chernett Jorey 13G 9.9% 5/30/2025
Event 5/27/2025
Alta Partners LLC 13G 6.2%
Checked 5% or less
3/10/2025
Event 2/28/2025
Dauntless Investment Group, LLC 13G 9.7% 3/3/2025
Event 2/26/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 13.5 k $4.06 k
2026 Q2 22 12.8 M $9.22 M
2026 Q1 24 2.84 M $2.80 M
2025 Q4 22 2.44 M $1.67 M
2025 Q3 21 1.36 M $1.10 M
2025 Q2 19 1.27 M $586 k
2025 Q1 17 1.53 M $885 k